Article

Advantage of the F(ab)’2 fragment over IgG for RIT and PRIT

2024-10-17

Abstract excerpt

Radioimmunotherapy (RIT) has proved clinically effective in the treatment of relapsed or consolidating NHL after chemotherapy. However, it is still at the clinical trial stage for the treatment of solid tumors. The efficacy of the treatment on this type of tumor is limited by hematological toxicity, which restricts the activities injected. Pre-targeted radioimmunotherapy (PRIT) enables radiolabeling to be carried...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 145446a1-3251-50bb-9ac9-a61ca75318dc
DOI: 10.1101/2024.10.16.617029

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Advantage of the F(ab)’2 fragment over IgG for RIT and PRITDOI 10.1101/2024.10.16.617029Read

A general approach to reduce off-target radioactivity in vivo via Tetrazine-Knock-Out (TKO)Semantic proximity Read

scFv-Fcs as a Radiotheranostic Platform for Targeting TRA-1-60 in Pancreatic CancersSemantic proximity Read

Bismuth-213 for Targeted Radionuclide Therapy: From Atom to BedsideSemantic proximity Read

Exploring the Potentials of Antibody–siRNA Conjugates in Tumor Cell Gene Silencing without Cationic AssistanceSemantic proximity Read

Targeted Nanoparticles: an Innovative Modality in the Treatment of CancerSemantic proximity Read

A novel format for recombinant antibody-interleukin-2 fusion proteins exhibits superior tumor-targeting properties in vivoSemantic proximity Read

Transgenic goats producing an improved version of cetuximab in milkSemantic proximity Read

Targeted therapy of breast cancer using PLAC1 antibody-drug conjugateSemantic proximity Read

Mathematical Modeling Unveils Optimization Strategies for Targeted Radionuclide Therapy of Blood CancersSemantic proximity Read

Functional relevance of in vivo half antibody exchange of an IgG4 therapeutic antibody-drug conjugate.Semantic proximity Read

In vitro and in vivo pre-clinical analysis of a F(ab')2 fragment of panitumumab for molecular imaging and therapy of HER1-positive cancersSemantic proximity Read

Engineering Fab' fragments for efficient F(ab)2 formation in Escherichia coli and for improved in vivo stability.Semantic proximity Read